The present invention relates to hydroxamate derivatives, isomers thereof, pharmaceutically acceptable salts thereof, hydrates thereof, or solvates thereof, the use thereof for preparing pharmaceutical compositions, pharmaceutical compositions containing the same, a method of treating disease using the compositions, and a method for preparing the hydroxamate derivatives.
本发明涉及羟
肟酸衍
生物、其同分异构体、药用可接受的盐、
水合物或溶剂化物,以及它们用于制备药物组合物的用途,包含它们的药物组合物,使用该组合物治疗疾病的方法,以及制备羟
肟酸衍
生物的方法。